MCGREVIN GENE R 13D and 13G filings for TriSalus Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2023-08-21 4:36 pm Purchase | 2023-08-10 | 13G | TriSalus Life Sciences, Inc. TLSI | MCGREVIN GENE R | 1,403,130 5.300% | 1,403,130![]() (New Position) | Filing |